Intervention Review

Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease

  1. Jimmy Chong2,
  2. Phillippa Poole1,*,
  3. Bonnie Leung2,
  4. Peter N Black3

Editorial Group: Cochrane Airways Group

Published Online: 11 MAY 2011

Assessed as up-to-date: 29 SEP 2010

DOI: 10.1002/14651858.CD002309.pub3

How to Cite

Chong J, Poole P, Leung B, Black PN. Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2011, Issue 5. Art. No.: CD002309. DOI: 10.1002/14651858.CD002309.pub3.

Author Information

  1. 1

    University of Auckland, Department of Medicine, Auckland, New Zealand

  2. 2

    University of Auckland, Auckland, New Zealand

  3. 3

    University of Auckland, (Deceased), Auckland, New Zealand

*Phillippa Poole, Department of Medicine, University of Auckland, Private Bag 92019, Auckland, New Zealand. p.poole@auckland.ac.nz.

Publication History

  1. Publication Status: New
  2. Published Online: 11 MAY 2011

SEARCH

  1. Current Version

    Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease

    Jimmy Chong, Phillippa Poole, Bonnie Leung and Peter N Black

    Article first published online: 11 MAY 2011 | DOI: 10.1002/14651858.CD002309.pub3

Previous versions of this article and their online publication dates

  1. Version 2

    Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease

    Claire Arandjus, Peter N Black and Phillippa Poole

    Article first published online: 21 JAN 2009 | DOI: 10.1002/14651858.CD002309.pub2

  2. Version 1

    Phosphodiasterase inhibitors for chronic obstructive pulmonary disease

    FSF Ram and K Parameswaren

    Article first published online: 18 OCT 2006 | DOI: 10.1002/14651858.CD002309